Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 3
2015 4
2016 5
2017 2
2018 3
2019 3
2020 7
2021 9
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

37 results
Results by year
Filters applied: . Clear all
Page 1
Management of carbapenem-resistant Enterobacteriaceae infections.
Durante-Mangoni E, Andini R, Zampino R. Durante-Mangoni E, et al. Among authors: andini r. Clin Microbiol Infect. 2019 Aug;25(8):943-950. doi: 10.1016/j.cmi.2019.04.013. Epub 2019 Apr 18. Clin Microbiol Infect. 2019. PMID: 31004767 Free article. Review.
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial.
Paul M, Daikos GL, Durante-Mangoni E, Yahav D, Carmeli Y, Benattar YD, Skiada A, Andini R, Eliakim-Raz N, Nutman A, Zusman O, Antoniadou A, Pafundi PC, Adler A, Dickstein Y, Pavleas I, Zampino R, Daitch V, Bitterman R, Zayyad H, Koppel F, Levi I, Babich T, Friberg LE, Mouton JW, Theuretzbacher U, Leibovici L. Paul M, et al. Among authors: andini r. Lancet Infect Dis. 2018 Apr;18(4):391-400. doi: 10.1016/S1473-3099(18)30099-9. Epub 2018 Feb 16. Lancet Infect Dis. 2018. PMID: 29456043 Clinical Trial.
Liver injury in remdesivir-treated COVID-19 patients.
Zampino R, Mele F, Florio LL, Bertolino L, Andini R, Galdo M, De Rosa R, Corcione A, Durante-Mangoni E. Zampino R, et al. Among authors: andini r. Hepatol Int. 2020 Sep;14(5):881-883. doi: 10.1007/s12072-020-10077-3. Epub 2020 Jul 28. Hepatol Int. 2020. PMID: 32725454 Free PMC article. No abstract available.
Dalbavancin for infective endocarditis: a single centre experience.
Durante-Mangoni E, Boccia F, Ursi MP, Karruli A, Andini R, Galdo M, Zampino R. Durante-Mangoni E, et al. Among authors: andini r. J Chemother. 2021 Jul;33(4):256-262. doi: 10.1080/1120009X.2020.1823119. Epub 2020 Oct 19. J Chemother. 2021. PMID: 33073724
Early experience with remdesivir in SARS-CoV-2 pneumonia.
Durante-Mangoni E, Andini R, Bertolino L, Mele F, Florio LL, Murino P, Corcione A, Zampino R. Durante-Mangoni E, et al. Among authors: andini r. Infection. 2020 Oct;48(5):779-782. doi: 10.1007/s15010-020-01448-x. Epub 2020 May 16. Infection. 2020. PMID: 32418190 Free PMC article.
Real-life experience with ceftobiprole in a tertiary-care hospital.
Durante-Mangoni E, Andini R, Mazza MC, Sangiovanni F, Bertolino L, Ursi MP, Paradiso L, Karruli A, Esposito C, Murino P, Corcione A, Zampino R. Durante-Mangoni E, et al. Among authors: andini r. J Glob Antimicrob Resist. 2020 Sep;22:386-390. doi: 10.1016/j.jgar.2020.03.010. Epub 2020 Apr 1. J Glob Antimicrob Resist. 2020. PMID: 32247081 Free article.
37 results